| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1556061A2 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 07/27/2005 | EP1556024A1 Pulsatile release compositions of milnacipran |
| 07/27/2005 | EP1556022A1 Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| 07/27/2005 | EP1556015A1 Extended, controlled release pharmaceutical compositions comprising charged polymers |
| 07/27/2005 | EP1556008A1 Use of bases for the manufacture of a medicament in the treatment of different forms of inflammatory dermatosis |
| 07/27/2005 | EP1556006A2 Water soluble sheet composition |
| 07/27/2005 | EP1556004A2 Pharmaceutical compositions for buccal delivery of pain relief medications |
| 07/27/2005 | EP1556003A2 Methods of administering and enhancing absorption of pharmaceutical agents |
| 07/27/2005 | EP1555976A2 Propofol with cysteine |
| 07/27/2005 | EP1320295A4 Collagen/polysaccharide bilayer matrix |
| 07/27/2005 | EP1257299B1 Radioactive therapeutic liposomes |
| 07/27/2005 | EP1235557B1 Gastroretentive controlled release pharmaceutical dosage forms |
| 07/27/2005 | EP1187601B1 Novel preparation and administration form comprising an acid-labile proton pump inhibitor |
| 07/27/2005 | EP1183029B1 Pharmaceutical preparation containing diamorphine and vitamin e and its utilization for treating opiate addiction |
| 07/27/2005 | EP1124537B1 Propofol composition |
| 07/27/2005 | EP1107733B1 Oral liquid mucoadhesive compositions |
| 07/27/2005 | EP1071403B1 Pharmaceutical composition containing a statin and aspirin |
| 07/27/2005 | EP1067896B1 Topical compositions comprising ascorbyl-phosphoryl-cholesterol |
| 07/27/2005 | EP0996436B1 Pharmaceutical formulations containing poorly soluble drug substances |
| 07/27/2005 | EP0952855B1 Use of hyaluronan in gene therapy |
| 07/27/2005 | EP0920510B1 GnRH-LEUKOTOXIN CHIMERAS |
| 07/27/2005 | CN1646702A Protein carrier system for therapeutic oligonucleotides |
| 07/27/2005 | CN1646675A Targeted controlled delivery compositions activated by changes in pH or salt concentration |
| 07/27/2005 | CN1646627A Solid emulsions based on thermoplastic elastomers |
| 07/27/2005 | CN1646568A Iron dextrin compounds for the treatment of iron deficiency anaemia |
| 07/27/2005 | CN1646538A Topiramate salts and compositions comprising and methods of making and using the same |
| 07/27/2005 | CN1646527A Medicaments containing BETAMIMETICS drugs and a novel anticholinesterase drug |
| 07/27/2005 | CN1646193A Bisphosphonic acid for the treatment and prevention of osteoporosis |
| 07/27/2005 | CN1646174A Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| 07/27/2005 | CN1646173A Microparticles comprising carbohydrate beads covalently linked with allergen |
| 07/27/2005 | CN1646172A Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation |
| 07/27/2005 | CN1646171A Novel biomaterials, their preparation and use |
| 07/27/2005 | CN1646170A Temperature responsive delivery systems |
| 07/27/2005 | CN1646169A Injectable veterinary composition for small animals |
| 07/27/2005 | CN1646165A Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 07/27/2005 | CN1646160A Anti-alpha V beta 6 antibodies |
| 07/27/2005 | CN1646159A Immunoadjuvant |
| 07/27/2005 | CN1646154A Albumin-fused anti-angiogenesis peptides |
| 07/27/2005 | CN1646151A Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis |
| 07/27/2005 | CN1646145A Preparations for topical skin use and treatment |
| 07/27/2005 | CN1646140A Use of a compound having the ability to release CO in preparation of pharmaceutical compositions for treatment of inflammation |
| 07/27/2005 | CN1646136A Pharmaceutical compositions comprising active vitamin D compounds |
| 07/27/2005 | CN1646128A Solid dispersion composition |
| 07/27/2005 | CN1646126A Medicaments containing steroids and a novel anticholinesterase drug |
| 07/27/2005 | CN1646114A Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
| 07/27/2005 | CN1646112A A herbal molecule as potential anti-leukemic drug |
| 07/27/2005 | CN1646108A Aerosol formulation for inhalation comprising a tiotropium salt |
| 07/27/2005 | CN1646107A A method for treating carrier particles and its use |
| 07/27/2005 | CN1646106A Capsule preparation |
| 07/27/2005 | CN1646105A Bioadhesive composition comprising a polysaccharide and a polycarboxylated polymer |
| 07/27/2005 | CN1646104A Dry granulated formulations of azithromycin |
| 07/27/2005 | CN1646103A 高药物载荷片剂 High drug load tablets |
| 07/27/2005 | CN1646102A Pharmaceutical preparation containing oxycodone and naloxone |
| 07/27/2005 | CN1646100A Dispersed solid-containing complex carbohydrate |
| 07/27/2005 | CN1646099A Powder formulations suitable for inhalation |
| 07/27/2005 | CN1646098A Pharmaceutical formulation comprising melatonin |
| 07/27/2005 | CN1646094A A stable pharmaceutical formulation comprising torsemide modification II |
| 07/27/2005 | CN1646068A Therapeutic polyesters and polyamides |
| 07/27/2005 | CN1646029A Encapsulated agglomeration of microcapsules and method for the preparation thereof |
| 07/27/2005 | CN1644605A Nano particles of poly-lactic acid or polyethyllactide propyllactide for packing plant extract |
| 07/27/2005 | CN1644215A Block polymer for eyes |
| 07/27/2005 | CN1212154C Gel delivery vehicles for anticellular proliferative agent |
| 07/27/2005 | CN1212080C Composition containing fat-soluble vitamins |
| 07/26/2005 | US6921816 Supplying nucleic acids into cell organelles |
| 07/26/2005 | US6921574 Hydrogel adhesives for use on hair or fiber-populated surfaces |
| 07/26/2005 | US6921542 Preparation of a therapeutic composition |
| 07/26/2005 | US6921541 Formulations and methods for providing prolonged local anesthesia |
| 07/26/2005 | US6921531 Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy |
| 07/26/2005 | US6921525 Diagnosis of cardiovascular disorders |
| 07/26/2005 | CA2470200C Pharmaceutical composition |
| 07/26/2005 | CA2363902C Process and system for controlled-release drug delivery |
| 07/26/2005 | CA2322644C Pharmaceutical composition of topiramate |
| 07/26/2005 | CA2269115C Monovalent antibody fragments |
| 07/26/2005 | CA2233108C Complex of y-cyclodextrin and retinol or retinol derivatives, processes for their preparation and their use |
| 07/26/2005 | CA2153326C Taxane formulations comprising phospholipids |
| 07/26/2005 | CA2096430C Use of an organopolysiloxane and an acrylamide/neutralized 2-acrylamido-2-methylpropanesulfonic acid cured copolymer in cosmetics or topical applications |
| 07/21/2005 | WO2005066410A1 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 07/21/2005 | WO2005066348A2 Interleukin-12 targeted to oncofoetal fibronectin |
| 07/21/2005 | WO2005066238A1 Medicinal compositions and method for the preparation thereof |
| 07/21/2005 | WO2005066215A1 Cohesive gels form cross-linked hyaluronan and/or hylan, their preparation and use |
| 07/21/2005 | WO2005066214A1 Hyaluronic acid derivative and drug containing the same |
| 07/21/2005 | WO2005066213A1 A simplified method to retrieve chitosan from acidic solutions thereof |
| 07/21/2005 | WO2005066212A1 Pseudoproteoglycan and use thereof |
| 07/21/2005 | WO2005066203A2 Targeted immunogens |
| 07/21/2005 | WO2005066114A1 Compounds for diagnosis, treatment and prevention of bone injury and metabolic disorders |
| 07/21/2005 | WO2005065718A2 Antitumour treatments with metxia-p450 and cyclophosphamide or 5t4 vaccine |
| 07/21/2005 | WO2005065717A2 Liquid formulations of antibody conjugates |
| 07/21/2005 | WO2005065716A1 Hard capsule and method for producing same |
| 07/21/2005 | WO2005065714A1 Intranasal administration of glucose-regulating peptides |
| 07/21/2005 | WO2005065713A2 Topically applied medicament for animals |
| 07/21/2005 | WO2005065710A1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 07/21/2005 | WO2005065709A2 Lyophilized antibody conjugate formulation |
| 07/21/2005 | WO2005065708A2 Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability |
| 07/21/2005 | WO2005065706A1 Pharmaceutical composition for thrombin peptide derivatives |
| 07/21/2005 | WO2005065705A1 Prefilled syringe preparation of calcitonins |
| 07/21/2005 | WO2005065697A1 Method for the photostabilisation of phycobiliproteins in an aqueous extract, compositions containing stabilised phycobiliproteins and use of stabilised phycobiliproteins |
| 07/21/2005 | WO2005065682A2 Rabeprazole containing formulation |
| 07/21/2005 | WO2005065677A1 Fat emulsion for dissolving or dispersing paclitaxel or docetaxel |
| 07/21/2005 | WO2005065676A1 Fat emulsion containing paclitaxel or docetaxel |